Clinical Trials Browser

Phase 3 × Neoplasm Metastasis × Imatinib Mesylate × Clear all

NCT00812240 2023-02-01

Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)

Phase 3 Terminated

GastrointestinalSarcoma

Neoplasm Metastasis, Gastrointestinal Stromal Tumors